Advertisement
Review Article| Volume 32, ISSUE 3, P391-406, September 2012

Download started.

Ok

Alcohol Biomarkers

      Excessive alcohol consumption poses significant immediate and long-term health risks. The search for sensitive and specific laboratory tests suitable for screening, diagnosis, and risk/severity assessment of patients with alcohol use disorders and for monitoring and motivating patients undergoing rehabilitation treatment for alcohol abuse is an active area of clinical research. The other growing use of these biomarkers is for maternal and neonatal screening. These markers can potentially be applied to the management of pregnant women with alcohol use disorders and may allow for earlier identification and treatment of infants at risk for fetal alcohol syndrome and related disorders. A number of promising alcohol biomarkers are being investigated for their potential applications in these settings. These biomarkers fall into two categories, indirect and direct. Indirect markers are those that reflect the toxic effects of ethanol on organs, tissues, or body biochemistry. Direct biomarkers are products of ethanol metabolism. The most promising of these direct markers are the longer-lived, nonoxidative products of ethanol metabolism.
      Center for Substance Abuse Treatment
      The role of biomarkers in the treatment of alcohol use disorders.
      • Hannuksela M.
      • Liisanatti M.
      • Nissinen A.
      • et al.
      Biochemical markers of alcoholism.
      • Litten R.
      • Bradley A.
      • Moss H.
      Alcohol biomarkers in applied settings: recent advances and future research opportunities.
      • Bakhireva L.N.
      • Savage D.D.
      Focus on: biomarkers of fetal alcohol exposure and fetal alcohol effects.
      • Excessive alcohol consumption poses a wide variety of significant immediate and long-term health risks.
      • Ethanol biomarkers have clinical utility for detection, diagnosis, and treatment of alcohol use disorders and for screening for fetal alcohol exposure.
      • Indirect biomarkers are those that reflect the toxic effects of ethanol on organs, tissues, or body biochemistry, whereas direct biomarkers are products of ethanol metabolism.
      • Indirect biomarkers include liver enzymes (aspartate aminotransferase, alanine aminotransferase, and γ-glutamyltransferase), carbohydrate-deficient transferrin, and mean corpuscular volume.
      • Direct biomarkers include acetaldehyde adducts, ethyl glucuronide, ethyl sulfate, phosphatidylethanol, and the fatty acid ethyl esters.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Center for Substance Abuse Treatment
        The role of biomarkers in the treatment of alcohol use disorders.
        Substance Abuse treatment Advisory. 2006; 5 (Accessed April 29, 2012)
        • Hannuksela M.
        • Liisanatti M.
        • Nissinen A.
        • et al.
        Biochemical markers of alcoholism.
        Clin Chem Lab Med. 2007; 45: 953-961
        • Litten R.
        • Bradley A.
        • Moss H.
        Alcohol biomarkers in applied settings: recent advances and future research opportunities.
        Alcohol Clin Exp Res. 2010; 34: 955-967
        • Bakhireva L.N.
        • Savage D.D.
        Focus on: biomarkers of fetal alcohol exposure and fetal alcohol effects.
        Alcohol Res Health. 2011; 34: 56-63
        • Substance Abuse and Mental Health Services Administration
        Results from the 2010 National Survey on Drug Use and Health: summary of national findings, NSDUH Series H-41, HHS Publication No. (SMA) 11-4658.
        Substance Abuse and Mental Health Services Administration, Rockville (MD)2011 (Accessed April 29, 2012)
        • Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities, Division of Birth Defects and Developmental Disabilities
        Data and statistics in the United States.
        (In: Fetal alcohol spectrum disorders) (Accessed April 29, 2012)
        • Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion Alcohol Use and Health
        (In: Alcohol and Public Health Fact Sheets) (Accessed April 29, 2012)
        • Schuckit M.A.
        Ethanol and methanol.
        in: Brunton L.L. Chabner B.A. Knollmann B.C. Goodman & Gilman's The Pharmacological basis of therapeutics. 12th edition. McGraw-Hill, New York2011 (Accessed March 30, 2012)
        • Tuma J.
        • Casey C.
        Dangerous byproducts of alcohol breakdown: focus on adducts.
        Alcohol Res Health. 2003; 27: 285-290
        • Niemela O.
        • Alatalo P.
        Biomarkers of alcohol consumption and related liver disease.
        Scand J Clin Lab Invest. 2010; 70: 305-312
        • Niemela O.
        Biomarkers in alcoholism.
        Clin Chim Acta. 2007; 377: 39-49
        • Das S.
        • Dhanya L.
        • Vasudevan D.
        Biomarkers of alcoholism: an updated review.
        Scand J Clin Lab Invest. 2008; 68: 81-92
        • Delanghe J.
        • De Buyzere M.
        Carbohydrate deficient transferrin and forensic medicine.
        Clin Chim Acta. 2009; 406: 1-7
        • Allen J.
        • Litten R.
        • Fertig J.
        • et al.
        Carbohydrate-deficient transferrin: an aid to early recognition of alcohol relapse.
        Am J Addict. 2001; 10: 24-28
        • Helander A.
        • Wielders J.
        • Jeppsson J.
        • et al.
        Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: II.
        Clin Chem Lab Med. 2010; 48: 1585-1592
        • Sillanaukee P.
        • Strid N.
        • Allen J.
        • et al.
        Possible reasons why heavy drinking increases carbohydrate-deficient transferrin.
        Alcohol Clin Exp Res. 2001; 25: 34-40
        • Golka K.
        • Wiese A.
        Carbohydrate-deficient transferrin (CDT)—a biomarker for long-term alcohol consumption.
        J Toxicol Environ Health B. 2004; 7: 319-337
        • Flemming M.
        • Anton R.
        • Spies C.
        A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels.
        Alcohol Clin Exp Res. 2004; 28: 1347-1355
        • Bergstrom J.
        • Helander A.
        Influence of alcohol use, ethnicity, age, gender, BMI and smoking on the serum transferrin glycoform pattern: implications for use of carbohydrate-deficient transferrin (CDT) as alcohol biomarker.
        Clin Chem Acta. 2008; 388: 59-67
        • Koivisto H.
        • Hietala J.
        • Anttila P.
        • et al.
        Long-term ethanol consumption and macrocytosis: diagnostic and pathogenic implications.
        J Lab Clin Med. 2006; 147: 191-196
        • Anton F.
        Carbohydrate-deficient transferrin for detection and monitoring of sustained heavy drinking.
        Alcohol. 2001; 25: 184-188
        • Hock B.
        • Schwarz M.
        • Domke I.
        • et al.
        Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (GGT) and mean corpuscular volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
        Addiction. 2005; 100: 1477-1486
        • Hietala J.
        • Koivisto H.
        • Anttila P.
        • et al.
        Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers.
        Alcohol Alcohol. 2006; 41: 528-533
        • Setshedi M.
        • Wands R.
        • de la Monte S.
        Acetaldehyde adducts in alcoholic liver disease.
        Oxidat Med Cell Longev. 2010; 3: 178-185
        • Freeman T.
        • Tuma D.
        • Thiele G.
        • et al.
        Recent advances in alcohol-induced adduct formation.
        Alcohol Clin Exp Res. 2005; 29: 1310-1316
        • Hietala J.
        • Kovisto H.
        • Latvala J.
        • et al.
        IgAs against acetetaldehyde-modified red cell protein as a marker of ethanol consumption in male alcoholic subjects, moderate drinkers, and abstainers.
        Alcohol Clin Exp Res. 2006; 30: 1693-1698
        • Hazelett S.
        • Liebelt R.
        • Brown W.
        • et al.
        Evaluation of acetaldehyde-modified hemoglobin and other markers of chronic heavy alcohol use: effects of gender and hemoglobin concentration.
        Alcohol Clin Exp Res. 1998; 22: 1813-1819
        • Hurme L.
        • Seppa K.
        • Rajaniem H.
        • et al.
        Chromatographically identified alcohol-induced haemoglobin adducts as markers of alcohol abuse among women.
        Eur J Clin Invest. 1998; 28: 87-94
        • Toennes A.
        • Wagner M.
        • Kauert G.
        Application of LC-TOF MS to analysis of hemoglobin acetaldehyde adducts in alcohol detoxification patients.
        Anal Bioanal Chem. 2010; 398: 769-777
        • Dahl H.
        • Stephanson N.
        • Beck O.
        • et al.
        Comparison of urinary excretion characteristics of ethanol and ethyl glucuronide.
        J Anal Toxicol. 2002; 26: 201-204
        • Wurst F.
        • Dressen S.
        • Allen J.
        • et al.
        Ethyl sulphate: a direct ethanol metabolite reflecting recent alcohol consumption.
        Addiction. 2006; 101: 204-211
        • Helander A.
        • Bottcher M.
        • Fehr C.
        • et al.
        Detection times for urinary ethyl glucuronide and ethyl sulfate in heavy drinkers during alcohol detoxification.
        Alcohol Alcohol. 2009; 44: 55-61
        • Jatlow P.
        • O'Malley S.
        Clinical (nonforensic) application of ethyl glucuronide measurement: Are we ready?.
        Alcohol Clin Exp Res. 2010; 34: 968-975
        • Stephenson N.
        • Dahl H.
        • Helander A.
        • et al.
        Direct quantification of ethyl glucuronide in clinical urine samples by liquid chromatograph-mass spectrometry.
        Ther Drug Monit. 2002; 24: 645-651
        • Wojcik M.
        • Hawthorne J.
        Sensitivity of commercial ethyl glucuronide (ETG) testing in screening for alcohol abstinence.
        Alcohol Alcohol. 2007; 42: 317-320
        • Reisfield G.
        • Goldberger B.
        • Pesce A.
        • et al.
        Ethyl glucuronide, ethyl sulfate, and ethanol in urine after intensive exposure to high ethanol content mouthwash.
        J Anal Toxicol. 2011; 35: 264-268
        • Reisfield G.
        • Goldberger B.
        • Crews B.
        • et al.
        Ethyl glucuronide, ethyl sulfate, and ethanol in urine after sustained exposure to ethanol-based hand sanitizer.
        J Anal Toxicol. 2011; 335: 85-91
        • Helander A.
        • Olsson I.
        • Dahl H.
        Postcollection synthesis of ethyl glucuronide by bacteria in urine may cause false identification of alcohol consumption.
        Clin Chem. 2007; 53: 1855-1857
        • Skipper G.
        • Weinmann W.
        • Thierauf A.
        • et al.
        Ethyl glulcuronide: a biomarker to identify alcohol use by health professionals recovering from substance use disorders.
        Alcohol Alcohol. 2004; 39: 445-449
        • Dahl H.
        • Carlsson A.
        • Hillgren K.
        • et al.
        Urinary ethyl glucuronide and ethyl sulfate testing for detection of recent drinking in an outpatient treatment program for alcohol and drug dependence.
        Alcohol Alcohol. 2011; 46: 278-282
        • Helander A.
        • Dahl H.
        Urinary tract infection: a risk factor for false-negative urinary ethyl glucuronide but not ethyl sulfate in the detection of recent alcohol consumption.
        Clin Chem. 2005; 51: 1728-1730
        • Bottcher M.
        • Beck O.
        • Helander A.
        Evaluation of a new immunoassay for urinary ethyl glucuronide testing.
        Alcohol Alcohol. 2008; 43: 46-48
        • Beyer J.
        • Vo T.
        • Gerostamoulos D.
        • et al.
        Validated method for the determination of ethylglucuronide and ethylsulfate in human urine.
        Anal Bioanal Chem. 2011; 400: 189-196
        • Favretto D.
        • Nalesso A.
        • Frison G.
        • et al.
        A novel and effective analytical approach for the LC-MS determination of ethyl glucuronide and ethyl sulfate in urine.
        Int J Legal Med. 2010; 124: 161-164
        • Jung B.
        • Caslavska J.
        • Thormann W.
        Determination of ethyl sulfate in human serum and urine by capillary zone electrophoresis.
        J Chromatogr A. 2008; 1206: 26-32
        • Hansson P.
        • Caron M.
        • Johnson G.
        • et al.
        Blood phosphatidylethanol as a marker of alcohol abuse: levels in alcoholic males during withdrawal.
        Alcohol Clin Exp Res. 1997; 21: 108-110
        • Varga A.
        • Hansson P.
        • Johnson G.
        • et al.
        Normalization rate and cellular localization of phosphatidylethanol in whole blood from chronic alcoholics.
        Clin Chim Acta. 2000; 299: 141-150
        • Nissinen A.
        • Makela S.
        • Vuoristo J.
        • et al.
        Immunological detection of in vitro formed phosphatidylethanol—an alcohol biomarker-with monoclonal antibodies.
        Alcohol Clin Exp Res. 2008; 32: 921-927
        • Wurst M.
        • Thon N.
        • Aradottir S.
        • et al.
        Phosphatidylethanol: normalization during detoxification, gender aspects and correlation with other biomarkers and self-reports.
        Addict Biol. 2010; 15: 88-95
        • Hartmann S.
        • Aradottir S.
        • Graf M.
        • et al.
        Phosphatidylethanol as a sensitive and specific biomarker-comparison with gamma-glutamyl transpeptidase, mean corpuscular volume and carbohydrate-deficient transferrin.
        Addict Biol. 2006; 12: 81-84
        • Stewart S.
        • Law T.
        • Randall P.
        • et al.
        Phosphatidylethanol and alcohol consumption in reproductive age women.
        Alcohol Clin Exp Res. 2010; 34: 488-492
        • Stewart S.
        • Reuben A.
        • Brzezinski W.
        • et al.
        Preliminary evaluation of phosphatidylethanol and alcohol consumption in patients with liver disease and hypertension.
        Alcohol Alcohol. 2009; 44: 464-467
        • Kip M.
        • Spies C.
        • Neumann T.
        • et al.
        The usefulness of direct ethanol metabolites in assessing alcohol intake in nonintoxicated male patients in an emergency room setting.
        Alcohol Clin Exp Res. 2008; 32: 1284-1291
        • Aradottir S.
        • Gulber A.
        • Gjerss S.
        • et al.
        Phosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients.
        Alcohol Alcohol. 2006; 41: 431-437
        • Nalesso A.
        • Viel G.
        • Cecchetto G.
        • et al.
        Quantitative profiling of phosphatidylethanol molecular species in human blood by liquid chromatography high resolution mass spectrometry.
        J. Chromatogr. A. 2011; 1218: 8423-8431
        • Zheng Y.
        • Beck O.
        • Helander A.
        Method development for routine liquid chromatography-mass spectrometry measurement of the alcohol biomarker phosphatidylethanol (PEth) in blood.
        Clin Chim Acta. 2011; 412: 1428-1435
        • Borucki K.
        • Dierkes J.
        • Wartberg J.
        • et al.
        In heavy drinkers, fatty acid ethyl esters remain elevated for up to 99 hours.
        Alcohol Clin Exp Res. 2007; 31: 423-427
        • Auwarter V.
        • Sporkert F.
        • Hartwig S.
        • et al.
        Fatty acid ethyl esters in hair as markers of alcohol consumption: segmental hair analysis of alcoholics, social drinkers, and teetotalers.
        Clin Chem. 2001; 47: 2114-2123
        • Chan D.
        • Caprara D.
        • Blanchette P.
        • et al.
        Recent developments in meconium and hair testing methods for the confirmation of gestational exposures to alcohol and tobacco smoke.
        Clin Biochem. 2004; 37: 429-438
        • Kulaga V.
        • Pragst F.
        • Fulga N.
        • et al.
        Hair analysis of fatty acid ethyl esters in the detection of excessive drinking in the context of fetal alcohol spectrum disorders.
        Ther Drug Monit. 2009; 31: 262-265
        • Hastedt M.
        • Herre S.
        • Pragst F.
        • et al.
        Workplace alcohol testing program by combined use of ethyl glucuronide and fatty acid ethyl esters in hair.
        Alcohol Alcohol. 2012; 47: 127-132
        • Pragst F.
        • Rothe M.
        • Moench B.
        • et al.
        Combined use of fatty acid ethyl esters and ethyl glucuronide in hair for diagnosis of alcohol abuse: interpretation and advantages.
        Forensic Sci Int. 2010; 196: 101-110
        • Pragst F.
        • Yegles M.
        Determination of fatty acid ethyl esters (FAEE) and ethyl glucuronide (EtG) in hair: a promising way for retrospective detection of alcohol abuse during pregnancy?.
        Ther Drug Monit. 2008; 30: 255-263
        • Susse S.
        • Selavka C.
        • Mieczkowski T.
        • et al.
        Fatty acid ethyl ester concentrations in hair and self-reported alcohol consumption in 644 cases from different origin.
        Forensic Sci Int. 2010; 196: 111-117
        • Wurst F.
        • Alexson S.
        • Wolfersdorf M.
        • et al.
        Concentration of fatty acid ethyl esters in hair of alcoholics: comparison to other biological state markers and self reported-ethanol intake.
        Alcohol Alcohol. 2004; 39: 33-38
        • Yegles M.
        • Labarthe A.
        • Auwarter V.
        • et al.
        Comparison of ethyl glucuronide and fatty acid ethyl ester concentrations in hair of alcoholics, social drinkers and teetotalers.
        Forensic Sci Int. 2004; 145: 167-173
        • Pichini S.
        • Pellegrini M.
        • Gareri J.
        • et al.
        Liquid chromatography-tandem mass spectrometry for fatty acid ethyl esters in meconium: assessment of prenatal exposure to alcohol in two European cohorts.
        J Pharmaceut Biomed Anal. 2008; 48: 927-933
        • Bakdash A.
        • Burger P.
        • Goecke T.
        • et al.
        Quantification of fatty acid ethyl esters (FAEE) and ethyl glucuronide (EtG) in meconium from newborns for detection of alcohol abuse in a maternal health evaluation study.
        Anal Bioanal Chem. 2010; 396: 2469-2477
        • Moore C.
        • Jones J.
        • Lewis D.
        Prevalence of fatty acid ethyl esters in meconium specimens.
        Clin Chem. 2003; 49: 133-136
        • Bearer C.
        • Santiago L.
        • O'Riordan M.
        • et al.
        Fatty acid ethyl esters: quantitative biomarkers for maternal alcohol consumption.
        J Pediatr. 2005; 146: 824-830
        • Goh Y.
        • Hutson J.
        • Lum L.
        • et al.
        Rates of fetal alcohol exposure among newborns in a high-risk obstetric unit.
        Alcohol. 2010; 44: 629-634
        • Peterson J.
        • Kirchner H.
        • Xue W.
        • et al.
        Fatty acid ethyl esters in meconium are associated with poorer neurodevelopmental outcomes to two years of age.
        J Pediatr. 2008; 152: 788-792
        • Hutson J.
        • Rao C.
        • Fulga N.
        • et al.
        An improved method for rapidly quantifying fatty acid ethyl esters in meconium suitable for prenatal alcohol screening.
        Alcohol. 2010; 45: 193-199
        • Society of Hair Testing
        Consensus of the Society of Hair Testing on hair testing for chronic excessive alcohol consumption.
        (Accessed April 30, 2012)
        • Jones J.
        • Jones M.
        • Plate C.
        • et al.
        Liquid chromatography-tandem mass spectrometry assay to detect ethyl glucuronide in human fingernail: comparison to hair and gender differences.
        Am J Anal Chem. 2012; 3: 83-91
        • Hartwig S.
        • Auwarter V.
        • Pragst F.
        Effect of hair care and hair cosmetics as markers of chronically elevated alcohol consumption.
        Forensic Sci Int. 2003; 131: 90-97
        • U.S. Drug Testing Laboratories (USDTL)
        EtOH, a new alcohol biomarker that tests at risk newborns for heavy exposure to alcohol in utero.
        (In: Testing services) (Accessed April 14, 2012)